Vivos Therapeutics Inc Q2 2023 Earnings Call Transcript - Thomson StreetEvents

Vivos Therapeutics Inc Q2 2023 Earnings Call Transcript

Vivos Therapeutics Inc Q2 2023 Earnings Call Transcript - Thomson StreetEvents
Vivos Therapeutics Inc Q2 2023 Earnings Call Transcript
Published Aug 16, 2023
Published Aug 16, 2023
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of VVOS.OQ earnings conference call or presentation 16-Aug-23 10:00pm GMT

  
Report Type:

Transcript

Source:
Company:
Vivos Therapeutics Inc
Ticker
VVOS.OQ
Time
10:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Scott Henry - Roth Capital Partners - Analyst : Thank you and good afternoon. Couple of questions, first, the negative impact of this AGGA device, do you still-- are you still noticing any impact at this point in time, or it's blown over?


Question: Scott Henry - Roth Capital Partners - Analyst : Okay. And then I know you made some comments on growth in the second half of '23, but more specifically, Q3, you expect sequential growth over Q2? I mean, Q2 kind of a lower base, just want to get a sense you expect improvement over that number?


Question: Scott Henry - Roth Capital Partners - Analyst : Okay. And then on the spending side, when you look at the 2Q numbers, do you expect cost cutting beyond there or should we think about 2Q as a base?


Question: Scott Henry - Roth Capital Partners - Analyst : Okay. Great. Final question from me. In 2Q, the revenue per VIP sign up was down a bit from Q1, what do you think is more reflective going forward, Q1 or Q2 or somewhere in between?


Question: Scott Henry - Roth Capital Partners - Analyst : No, I was talking about revenue per VIP sign up.


Question: Scott Henry - Roth Capital Partners - Analyst : If I take the VIP number divided by 43.


Question: Scott Henry - Roth Capital Partners - Analyst : Okay. All right. Great. Thank you for the color and thank you for taking the question.

Table Of Contents

Vivos Therapeutics Inc Annual Shareholders Meeting Transcript – 2024-11-26 – US$ 54.00 – Edited Transcript of VVOS.OQ shareholder or annual meeting 26-Nov-24 5:00pm GMT

Vivos Therapeutics Inc Q3 2024 Earnings Call Transcript – 2024-11-14 – US$ 54.00 – Edited Transcript of VVOS.OQ earnings conference call or presentation 14-Nov-24 10:00pm GMT

Vivos Therapeutics Inc Q2 2024 Earnings Call Transcript – 2024-08-14 – US$ 54.00 – Edited Transcript of VVOS.OQ earnings conference call or presentation 14-Aug-24 9:00pm GMT

Vivos Therapeutics Inc Q4 2023 Earnings Call Transcript – 2024-03-28 – US$ 54.00 – Edited Transcript of VVOS.OQ earnings conference call or presentation 28-Mar-24 9:00pm GMT

Vivos Therapeutics Inc Q3 2023 Earnings Call Transcript – 2023-11-14 – US$ 54.00 – Edited Transcript of VVOS.OQ earnings conference call or presentation 14-Nov-23 10:00pm GMT

Vivos Therapeutics Inc Q1 2023 Earnings Call Transcript – 2023-06-08 – US$ 54.00 – Edited Transcript of VVOS.OQ earnings conference call or presentation 8-Jun-23 9:00pm GMT

Vivos Therapeutics Inc Q4 2022 Earnings Call Transcript – 2023-03-30 – US$ 54.00 – Edited Transcript of VVOS.OQ earnings conference call or presentation 30-Mar-23 9:00pm GMT

Vivos Therapeutics Inc at Emerging Growth Conference (Virtual) Transcript – 2023-02-22 – US$ 54.00 – Edited Transcript of VVOS.OQ presentation 22-Feb-23 5:35pm GMT

Vivos Therapeutics Inc Annual Shareholders Meeting Transcript – 2022-08-25 – US$ 54.00 – Edited Transcript of VVOS.OQ shareholder or annual meeting 25-Aug-22 8:00pm GMT

Vivos Therapeutics Inc Q4 2021 Earnings Call Transcript – 2022-03-31 – US$ 54.00 – Edited Transcript of VVOS.OQ earnings conference call or presentation 31-Mar-22 9:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Vivos Therapeutics Inc Q2 2023 Earnings Call Transcript" Aug 16, 2023. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2023-Vivos-Therapeutics-Inc-Earnings-Call-T15696058>
  
APA:
Thomson StreetEvents. (2023). Vivos Therapeutics Inc Q2 2023 Earnings Call Transcript Aug 16, 2023. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2023-Vivos-Therapeutics-Inc-Earnings-Call-T15696058>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.